|

Semaglutide 14 MG [Rybelsus] Clinical Trials

2 actively recruiting trials

Also known as: Rybelsus

Pipeline

Phase 4: 2

Top Sponsors

  • Rigshospitalet, Denmark1
  • National Institute of Cardiology, Warsaw, Poland1

Indications

  • Diabetes2
  • Renal Transplant Complication Primary Non-Function1
  • PreDiabetes1
  • Heart Disease1
  • Coronary Artery Disease1

Other2 trials

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
Phase 4
Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.